These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9469239)

  • 21. The sensitivity of the Spontaneous Selective Attention Test (SSAT): a study of schizophrenic inpatients and outpatients versus normal controls.
    Myles-Worsley M; Coon H; Byerley W
    Schizophr Res; 1998 May; 31(2-3):131-9. PubMed ID: 9689717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocognitive performance and negative symptoms: are they equal in explaining disability in schizophrenia outpatients?
    Villalta-Gil V; Vilaplana M; Ochoa S; Haro JM; Dolz M; Usall J; Cervilla J;
    Schizophr Res; 2006 Oct; 87(1-3):246-53. PubMed ID: 16859898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia.
    Basso MR; Nasrallah HA; Olson SC; Bornstein RA
    Schizophr Res; 1998 May; 31(2-3):99-111. PubMed ID: 9689714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Tan YL; He S; Kosten TA; Kosten TR
    Schizophr Res; 2013 Feb; 143(2-3):301-6. PubMed ID: 23238053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cognitive remediation on neurocognitive functions and psychiatric symptoms in schizophrenia inpatients.
    Gharaeipour M; Scott BJ
    Schizophr Res; 2012 Dec; 142(1-3):165-70. PubMed ID: 23102691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments.
    Bell MD; Lysaker PH; Milstein RM; Beam-Goulet JL
    Psychiatry Res; 1994 Oct; 54(1):51-8. PubMed ID: 7701028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensory input deficits and negative symptoms in schizophrenic patients.
    Braff DL
    Am J Psychiatry; 1989 Aug; 146(8):1006-11. PubMed ID: 2750971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
    Light GA; Braff DL
    Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.
    Brazo P; Delamillieure P; Morello R; Halbecq I; Marié RM; Dollfus S
    Psychiatry Res; 2005 Jan; 133(1):45-55. PubMed ID: 15698676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Stroop task and attention deficits in schizophrenia: a critical evaluation of card and single-trial Stroop methodologies.
    Perlstein WM; Carter CS; Barch DM; Baird JW
    Neuropsychology; 1998 Jul; 12(3):414-25. PubMed ID: 9673997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Information processing in schizophrenia and bipolar disorder: a discriminant analysis.
    Tam WC; Sewell KW; Deng HC
    J Nerv Ment Dis; 1998 Oct; 186(10):597-603. PubMed ID: 9788635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between insight and theory of mind in schizophrenia.
    Konstantakopoulos G; Ploumpidis D; Oulis P; Patrikelis P; Nikitopoulou S; Papadimitriou GN; David AS
    Schizophr Res; 2014 Jan; 152(1):217-22. PubMed ID: 24321712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the dysexecutive syndrome in schizophrenia.
    Evans JJ; Chua SE; McKenna PJ; Wilson BA
    Psychol Med; 1997 May; 27(3):635-46. PubMed ID: 9153684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further evidence for a deficit in switching attention in schizophrenia.
    Smith GL; Large MM; Kavanagh DJ; Karayanidis F; Barrett NA; Michie PT; O'Sullivan BT
    J Abnorm Psychol; 1998 Aug; 107(3):390-8. PubMed ID: 9715574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does sex influence the relation between symptoms and neurocognitive functions in schizophrenia?
    Malla AK; Norman RM; Morrison-Stewart S; Williamson PC; Helmes E; Cortese L
    J Psychiatry Neurosci; 2001 Jan; 26(1):49-54. PubMed ID: 11212594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms.
    Gurpegui M; Alvarez E; Bousoño M; Ciudad A; Carlos Gómez J; Olivares JM
    Eur Neuropsychopharmacol; 2007 Nov; 17(11):725-34. PubMed ID: 17543505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.